The most effective and promising population health strategies to advance human papillomavirus vaccination

Robert M. Jacobson, Amenah A. Agunwamba, Jennifer St. Sauver, Lila J Rutten

Research output: Contribution to journalArticle

15 Scopus citations


The US is failing to make substantive progress toward improving rates of human papillomavirus vaccine uptake. While the Healthy People 2020 goal for human papillomavirus (HPV) vaccination is 80%, the three-dose completion rate in the US in 2014 for 13- to 17-year-old females is less than 40%, and the rate for males is just above 20%. Experts point to a number of reasons for the poor HPV vaccination rates including parental concerns about safety, necessity, and timing. However, the evidence refuting these concerns is substantial. Efforts focusing on education and communication have not shown promise, but several population health strategies have reminder/recall systems; practice-focused strategies targeting staff, clinicians, and parents; assessment and feedback activities; and school-based HPV vaccination programs.

Original languageEnglish (US)
Pages (from-to)257-269
Number of pages13
JournalExpert Review of Vaccines
Issue number2
StatePublished - Feb 1 2016



  • adolescent
  • child
  • health knowledge, attitudes, practice
  • immunization
  • immunization programs
  • Papillomavirus vaccines
  • United States
  • vaccination

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this